Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Berberis vulgaris** is a medicinal plant, commonly known as barberry, widely used in traditional medicine and as a food additive, especially in Iran[1][3]. All parts of the plant (fruit, bark, root, and stem) contain pharmacologically active compounds, including alkaloids such as berberine, oxyacanthine, and berbamine, as well as vitamins (notably vitamin C and vitamin K), triterpenoids, and phenolics[1]. The main mechanisms of action include anti-inflammatory and immunomodulatory effects via suppression of pro-inflammatory cytokines and induction of T regulatory cells, antioxidation, antihistaminic and anticholinergic effects, and possible calcium channel blockade[1][3]. The plant has demonstrated experimental efficacy in animal models and cell lines for conditions such as cancer, diabetes, hypertension, hyperlipidemia, bacterial infections, and pain[1][3]. In traditional medicine and homeopathy, it is used for kidney stone pain and various inflammatory conditions[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on berberis vulgaris.